Align Technology - ALGN Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $336.27
  • Forecasted Upside: 11.20%
  • Number of Analysts: 10
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
▼ -10.67 (-3.41%)

This chart shows the closing price for ALGN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Align Technology Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALGN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALGN

Analyst Price Target is $336.27
▲ +11.20% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Align Technology in the last 3 months. The average price target is $336.27, with a high forecast of $450.00 and a low forecast of $225.00. The average price target represents a 11.20% upside from the last price of $302.39.

This chart shows the closing price for ALGN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 10 contributing investment analysts is to hold stock in Align Technology. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/26/2024Leerink PartnrsReiterated RatingMarket PerformLow
2/26/2024SVB LeerinkInitiated CoverageMarket Perform$310.00Low
2/2/2024The Goldman Sachs GroupBoost TargetSell ➝ Sell$197.00 ➝ $225.00Low
2/1/2024Piper SandlerBoost TargetOverweight ➝ Overweight$290.00 ➝ $335.00Low
1/30/2024UBS GroupBoost TargetNeutral ➝ Neutral$200.00 ➝ $260.00Low
12/11/2023The Goldman Sachs GroupDowngradeNeutral ➝ Sell$197.00Low
10/27/2023UBS GroupDowngradeBuy ➝ Neutral$200.00Low
10/26/2023Piper SandlerLower TargetOverweight ➝ Overweight$370.00 ➝ $290.00Low
10/26/2023Morgan StanleyLower TargetOverweight ➝ Overweight$415.00 ➝ $378.00Low
10/24/2023Stifel NicolausLower TargetBuy ➝ Buy$430.00 ➝ $390.00Low
10/11/2023Evercore ISILower Target$400.00 ➝ $320.00Low
9/14/2023OTR GlobalUpgradeMixed ➝ PositiveLow
8/30/2023HSBCInitiated CoverageBuy$450.00Low
8/24/2023Stifel NicolausBoost TargetBuy ➝ Buy$390.00 ➝ $430.00Low
7/27/2023Morgan StanleyBoost TargetOverweight$383.00 ➝ $415.00Low
7/27/2023Jefferies Financial GroupBoost Target$367.00 ➝ $400.00Low
7/27/2023Piper SandlerBoost Target$370.00 ➝ $415.00Low
7/27/2023Robert W. BairdBoost Target$385.00 ➝ $406.00Low
6/16/2023OTR GlobalDowngradePositiveLow
4/27/2023VNET GroupReiterated RatingMaintainsLow
4/27/2023Bank of AmericaBoost Target$190.00 ➝ $225.00Low
4/27/2023Piper SandlerBoost Target$360.00 ➝ $370.00Low
4/19/2023Morgan StanleyBoost TargetOverweight$314.00 ➝ $383.00Low
4/18/2023Stifel NicolausBoost TargetBuy$375.00 ➝ $390.00Low
3/31/2023OTR GlobalUpgradeMixed ➝ PositiveLow
3/23/2023CICC ResearchInitiated CoverageMarket PerformLow
2/2/2023Evercore ISIBoost TargetOutperform$230.00 ➝ $375.00Low
2/2/2023Stifel NicolausBoost TargetBuy$265.00 ➝ $375.00Low
2/2/2023The Goldman Sachs GroupUpgradeSell ➝ Neutral$165.00 ➝ $307.00Low
2/2/2023Robert W. BairdBoost TargetOutperform$260.00 ➝ $335.00Low
2/2/2023Piper SandlerBoost TargetOverweight$255.00 ➝ $360.00N/A
1/11/2023Piper SandlerBoost TargetOverweight$230.00 ➝ $255.00Low
10/27/2022The Goldman Sachs GroupLower TargetSell$250.00 ➝ $165.00Low
10/27/2022Morgan StanleyLower TargetOverweight$402.00 ➝ $314.00Low
10/27/2022Stifel NicolausLower Target$325.00 ➝ $265.00Low
10/27/2022Robert W. BairdLower Target$310.00 ➝ $260.00Low
10/27/2022Piper SandlerLower Target$300.00 ➝ $230.00Low
10/13/2022Piper SandlerLower TargetOverweight$340.00 ➝ $300.00Low
10/12/2022Stifel NicolausLower TargetBuy ➝ Buy$375.00 ➝ $325.00Low
9/9/2022Piper SandlerLower TargetOverweight$370.00 ➝ $340.00Low
7/29/2022UBS GroupLower TargetBuy$380.00 ➝ $370.00Low
7/28/2022StephensLower TargetOverweight$500.00 ➝ $375.00Low
7/28/2022Morgan StanleyLower TargetOverweight$438.00 ➝ $402.00Low
7/28/2022Evercore ISILower Target$310.00 ➝ $285.00Low
7/28/2022Robert W. BairdLower TargetOutperform$450.00 ➝ $410.00Low
7/28/2022The Goldman Sachs GroupDowngradeBuy ➝ Sell$380.00 ➝ $250.00Low
7/22/2022Piper SandlerLower TargetOverweight$440.00 ➝ $370.00Low
7/20/2022Morgan StanleyLower TargetOverweight$479.00 ➝ $438.00Low
7/18/2022UBS GroupLower Target$410.00 ➝ $380.00Low
7/14/2022Stifel NicolausLower TargetBuy$425.00 ➝ $375.00Low
6/15/2022Morgan StanleyLower TargetOverweight$524.00 ➝ $479.00Low
5/4/2022Credit Suisse GroupLower Target$722.00 ➝ $418.00Medium
4/28/2022Stifel NicolausLower Target$575.00 ➝ $425.00High
4/28/2022Morgan StanleyLower Target$575.00 ➝ $524.00High
4/28/2022Robert W. BairdLower TargetOutperform$625.00 ➝ $510.00High
4/28/2022Piper SandlerLower Target$600.00 ➝ $440.00High
4/26/2022UBS GroupLower TargetBuy$620.00 ➝ $500.00Medium
4/21/2022Piper SandlerLower TargetOverweight$740.00 ➝ $600.00High
2/3/2022Robert W. BairdLower Target$745.00 ➝ $650.00High
2/3/2022Stifel NicolausLower TargetBuy$675.00 ➝ $625.00High
2/3/2022Credit Suisse GroupLower TargetOutperform$782.00 ➝ $722.00High
1/31/2022UBS GroupUpgradeNeutral ➝ Buy$880.00 ➝ $620.00High
1/31/2022Morgan StanleyInitiated CoverageOverweight$575.00High
1/21/2022Stifel NicolausLower Target$750.00 ➝ $675.00High
11/1/2021William BlairReiterated RatingOutperformLow
10/28/2021The Goldman Sachs GroupDowngradeBuy$810.00High
10/28/2021Piper SandlerBoost TargetPositive ➝ Overweight$775.00 ➝ $825.00High
7/29/2021William BlairReiterated RatingOutperformHigh
7/29/2021Credit Suisse GroupBoost TargetOutperform ➝ Outperform$715.00 ➝ $732.00High
7/29/2021Piper SandlerBoost TargetOverweight$735.00 ➝ $775.00High
7/9/2021StephensUpgradeEqual Weight ➝ Overweight$600.00 ➝ $700.00Medium
7/8/2021Exane BNP ParibasInitiated CoverageOutperform$790.00Medium
7/8/2021BNP ParibasInitiated CoverageOutperform$790.00Medium
4/29/2021SVB LeerinkBoost TargetPositive ➝ Outperform$690.00 ➝ $770.00High
4/29/2021Credit Suisse GroupBoost TargetOutperform$693.00 ➝ $715.00High
4/29/2021Stifel NicolausBoost TargetBuy$650.00 ➝ $750.00High
4/29/2021Robert W. BairdBoost TargetOutperform$655.00 ➝ $745.00High
4/29/2021Piper SandlerBoost TargetOverweight$700.00 ➝ $735.00High
4/22/2021Berenberg BankUpgradeHold ➝ Buy$683.00Medium
4/15/2021SVB LeerinkBoost TargetOutperform$680.00 ➝ $690.00Medium
2/4/2021Evercore ISIBoost TargetOutperform$625.00 ➝ $680.00High
2/4/2021Credit Suisse GroupBoost TargetOutperform$618.00 ➝ $630.00High
2/4/2021SVB LeerinkBoost TargetOutperform$620.00 ➝ $680.00High
2/4/2021BarclaysBoost TargetEqual Weight$475.00 ➝ $555.00High
2/2/2021Piper SandlerBoost TargetOverweight$525.00 ➝ $610.00Low
1/4/2021Evercore ISIUpgradeIn-Line ➝ Outperform$625.00N/A
11/24/2020Credit Suisse GroupBoost TargetOutperform$432.00 ➝ $515.00Medium
11/24/2020SVB LeerinkBoost TargetOutperform$460.00 ➝ $520.00Medium
11/24/2020The Goldman Sachs GroupBoost TargetBuy$472.00 ➝ $535.00Medium
11/24/2020Robert W. BairdBoost TargetOutperform$450.00 ➝ $530.00Medium
11/23/2020Piper SandlerBoost TargetOverweight$500.00 ➝ $525.00Medium
10/28/2020Stifel NicolausBoost TargetBuy$460.00 ➝ $515.00Low
10/22/2020Robert W. BairdBoost Target$370.00 ➝ $450.00High
10/22/2020Stifel NicolausBoost TargetBuy$360.00 ➝ $460.00High
10/22/2020BarclaysBoost TargetEqual Weight$300.00 ➝ $400.00High
10/22/2020Piper SandlerBoost TargetOverweight$400.00 ➝ $500.00High
10/22/2020Jefferies Financial GroupBoost TargetBuy$355.00 ➝ $450.00High
10/22/2020Credit Suisse GroupBoost TargetOutperform$348.00 ➝ $432.00High
10/22/2020SVB LeerinkBoost TargetOutperform$340.00 ➝ $460.00High
7/29/2020Berenberg BankDowngradeBuy ➝ Hold$306.00Low
7/23/2020BarclaysDowngradeOverweight ➝ Equal Weight$225.00 ➝ $300.00High
7/23/2020SVB LeerinkBoost TargetOutperform$310.00 ➝ $340.00High
7/23/2020Piper SandlerBoost TargetOverweight$258.00 ➝ $345.00High
7/20/2020Bank of AmericaDowngradeNeutral ➝ Underperform$280.00Low
7/14/2020SVB LeerinkBoost TargetOutperform$260.00 ➝ $310.00High
6/12/2020OTR GlobalUpgradePositiveLow
6/12/2020Stifel NicolausBoost TargetBuy$275.00 ➝ $300.00Low
5/22/2020Stifel NicolausBoost TargetBuy$230.00 ➝ $275.00High
5/1/2020UBS GroupLower TargetNeutral$270.00 ➝ $245.00Low
4/30/2020SVB LeerinkReiterated RatingOutperformLow
4/30/2020Credit Suisse GroupLower TargetOutperform$320.00 ➝ $275.00Low
4/30/2020Robert W. BairdBoost TargetOutperform$225.00 ➝ $248.00Low
4/30/2020Piper SandlerLower TargetOverweight$275.00 ➝ $258.00Low
3/19/2020StephensLower TargetEqual Weight$220.00 ➝ $165.00High
3/13/2020Stifel NicolausLower TargetBuy$305.00 ➝ $275.00High
3/5/2020Robert W. BairdReiterated RatingBuy$325.00Medium
1/30/2020Piper SandlerBoost Target$240.00 ➝ $275.00Medium
1/28/2020UBS GroupBoost TargetNeutral$235.00 ➝ $280.00Medium
1/9/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$360.00Medium
11/19/2019StephensReiterated RatingHold$220.00Medium
11/18/2019Stifel NicolausBoost TargetBuy$290.00 ➝ $305.00Medium
10/24/2019Bank of AmericaBoost TargetNeutral$220.00 ➝ $240.00High
10/7/2019BarclaysLower TargetOverweight$300.00 ➝ $272.00High
10/7/2019GuggenheimDowngradeBuy ➝ Neutral$250.00 ➝ $200.00High
7/31/2019Piper Sandler CompaniesSet TargetBuy$240.00N/A
7/26/2019UBS GroupSet TargetHold$230.00Medium
7/26/2019Robert W. BairdLower TargetOutperform$336.00 ➝ $259.00Medium
7/25/2019Stifel NicolausLower TargetBuy$360.00 ➝ $290.00Low
7/25/2019Bank of AmericaDowngradeBuy ➝ NeutralMedium
7/25/2019Credit Suisse GroupLower TargetOutperform$340.00 ➝ $320.00High
7/25/2019Piper Sandler CompaniesLower TargetOverweight$350.00 ➝ $240.00High
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformMedium
4/26/2019UBS GroupSet TargetHold$325.00Low
4/25/2019Credit Suisse GroupBoost TargetOutperform$305.00 ➝ $316.00High
4/25/2019BarclaysBoost TargetOverweight ➝ Overweight$335.00 ➝ $355.00Low
4/25/2019Piper Sandler CompaniesBoost TargetOverweight$300.00 ➝ $350.00Medium
4/17/2019GuggenheimInitiated CoverageBuy ➝ Buy$335.00High
4/11/2019BarclaysSet TargetBuy$325.00Low
3/25/2019Credit Suisse GroupBoost TargetOutperform$270.00 ➝ $278.00Low
3/19/2019Piper Sandler CompaniesBoost TargetOverweight$250.00 ➝ $300.00Medium
3/14/2019OTR GlobalDowngradePositiveLow
3/5/2019Robert W. BairdBoost TargetOutperform ➝ Outperform$255.00 ➝ $286.00High
(Data available from 2/28/2019 forward)

News Sentiment Rating

0.83 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 24 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 21 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 25 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
  • 13 very positive mentions
  • 17 positive mentions
  • 9 negative mentions
  • 3 very negative mentions
  • 2 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 12 very positive mentions
  • 13 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
  • 21 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
  • 29 very positive mentions
  • 30 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Current Sentiment

  • 29 very positive mentions
  • 30 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Align Technology logo
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; and non-case products that include retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment. The Systems and Services segment offers iTero intraoral scanning system, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, and pay per scan services Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Read More

Today's Range

Now: $302.39
Low: $302.06
High: $309.16

50 Day Range

MA: $281.26
Low: $256.22
High: $316.88

52 Week Range

Now: $302.39
Low: $176.34
High: $413.20


557,407 shs

Average Volume

932,994 shs

Market Capitalization

$23.16 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Align Technology?

The following equities research analysts have issued stock ratings on Align Technology in the last twelve months: Bank of America Co., CICC Research, Evercore ISI, HSBC Holdings plc, Jefferies Financial Group Inc., Leerink Partnrs, Morgan Stanley, OTR Global, Piper Sandler, Robert W. Baird, Stifel Nicolaus,, SVB Leerink LLC, The Goldman Sachs Group, Inc., UBS Group AG, and VNET Group, Inc..
View the latest analyst ratings for ALGN.

What is the current price target for Align Technology?

11 Wall Street analysts have set twelve-month price targets for Align Technology in the last year. Their average twelve-month price target is $336.27, suggesting a possible upside of 10.8%. HSBC Holdings plc has the highest price target set, predicting ALGN will reach $450.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $225.00 for Align Technology in the next year.
View the latest price targets for ALGN.

What is the current consensus analyst rating for Align Technology?

Align Technology currently has 1 sell rating, 4 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ALGN, but not buy more shares or sell existing shares.
View the latest ratings for ALGN.

What other companies compete with Align Technology?

How do I contact Align Technology's investor relations team?

Align Technology's physical mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider's listed phone number is (602) 742-2000 and its investor relations email address is [email protected]. The official website for Align Technology is Learn More about contacing Align Technology investor relations.